Featured Editorial

1. Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity 1/16/2026

   Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.

2. Building A Culture Of Compliance In Clinical Supply 1/15/2026

   Build a resilient clinical supply operation by embedding export compliance into every process, from leadership to training, technology, and audits, turning regulatory adherence into a strategic advantage.

3. Global Clinical Supply Chain in Emerging Markets: Reliability, Compliance, Access 1/13/2026

   Emerging markets hold 2.5B potential patients, yet trials stall on fragile supply chains. A design-first blueprint shows how reliability, compliance, and last-mile access unlock resilient, patient-centric delivery worldwide.

4. Clinical Supply Is Not A Fix-It Function. It's A Planning Function. 1/9/2026

   Treating clinical supply as a late-stage fix creates delays, shortages, and cost overruns. Early planning—across DP availability, forecasting, QP release, labels, and IXRS—keeps trials on timeline and out of crisis.

5. Sales & Operations Planning for Small Teams: Aligning Clinical Supply 1/6/2026

   Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.

6. The Trends Shaping Clinical Trial Supply 12/22/2025

   Decentralized trials and biotech product needs are changing how investigational products reach patients. New market research reveals trends.

7. What 2025 FDA Warning Letters Tell Us About GMP Compliance 12/15/2025

   This analysis identifies key compliance trends and regional disparities by examining the 2025 U.S. FDA warning letters issued to drug product manufacturers posted between Jan. 1 and Dec. 9, 2025.

8. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

   Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.

9. Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development 11/17/2025

   The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.

10. On The Potency Assurance Journey, Travelers Need A Road Map 11/13/2025

    When regulatory expectations change by the phase, the route can be difficult and confusing to navigate for both new and experienced potency investigators.